LDN Video Interviews and Presentations

Radio Show interviews, and Presentations from the LDN 2013, 2014, 2016, 2017, 2018 and 2019 Conferences

They are also on our    Vimeo Channel    and    YouTube Channel

Gary - England: The Sinclair Method for Alcohol Addiction (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Gary from England shares his Alcohol Use Disorder and Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood.

Gary’s issue with drinking began in the nineties when social drinking began to creep into his private life as well. He states that he used to drink a few beers just in order to sleep, which began a vicious cycle leading to more beers and more money being spent.

His weeks would be made up of constant hangovers which impacted upon his ability to work properly. Recognising his problem, he began to research for a solution which is when he found out about how effective Low Dose Naltrexone (LDN) can be against alcoholism.

During this interview Gary discusses “Alcohol Use Disorder” (AUD) and how successful The Sinclair Method is in treating the problem. Simply explained, the patient takes a 50 mg Naltrexone tablet one hour before drinking alcohol. It negates the effects and over time, reduces the addictive aspects. She explains how this is safe and inexpensive and that the success rate is 78%.

This is a summary of Gary’s interview. Please listen to the rest of Gary’s story by clicking on the video above.

Nurse Practitioner Seth Merritt, LDN Radio Show (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Seth Merrit, LMT, FNP, CATOM, CLS

shares his Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood.

Seth Merritt is a nurse practitioner from Portland, Oregon who prescribes Low Dose Naltrexone (LDN). He himself takes LDN for psoriasis and has a great deal of success.

Having witnessed his own recovery on LDN, he was determined to ensure that others do not miss out on the opportunity to try the drug. 

In this interview he explains how he finds LDN to be very successful in treating many of his patients with fibromyalgia.

This is a summary of Seth Merritt’s interview. Please listen to the rest of Seth’s story by clicking on the video above.

Dr Samyadev Datta, LDN Radio Show (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr Samyadev Datta shares his Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood.

Dr Samyadev Datta was first introduced to Low Dose Naltrexone (LDN) in 2012 by Dr Pradeep Chopra, who explained the myriad of benefits LDN has in boosting the body’s immune system in order to combat diseases.

In his practice, Dr Datta primarily specialises in pain, particularly patients with Complex Regional Pain Syndrome (CRPS) and has found LDN to be very successful in these patients. 

In this interview he explains the complex relationship LDN has with opiates and painkillers, while providing an interesting insight into some cases in his practice.

This is a summary of Dr Samyadev Datta’s interview. Please listen to the rest of Dr Datta’s story by clicking on the video above.

Dr Ronald Hoffman Interviews Linda Elsegood on LDN and The LDN Book (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Linda Elsegood shares her Multiple Sclerosis (MS) and Low Dose Naltrexone (LDN) Story on the Intelligent Medicine Podcast with Donald Hoffman.

In 1969 at the age of 13, Linda had glandular fever (Epstein-Barr virus). She was seriously ill and away from school for six months. 

Late 1999 Linda’s mother had a serious heart attack and the trauma affected her badly. She was working full time, travelling two and a half hours every day and running the home. This excessive workload and stress began to take its toll on her health, and by May 2000 she had lost her balance, lost feeling in the left side of her face and her head, tongue and nose were numb with pins and needles.

In early December 2003 Linda started Low Dose Naltrexone (LDN), and the results were incredibly positive. By Christmas Linda was functioning again, and her liver tests were back to normal. She felt like herself again.

Linda founded the LDN Research Trust in May 2004. In this interview she says that it is the most exciting thing she has ever done. She is able to give many hours a week to the Trust, helping people to get LDN and trying to get it into clinical trials.

This is a summary of Linda Elsegood’s interview. Please listen to the rest of Linda’s story by clicking on the video above.

Dr Patrick Callas, LDN Radio Show 2016 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr Patrick Callas shares his Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood.

Dr Patrick Callas has his own practice on an island on the West Coast of British Columbia and Canada, a small community of 10,000 people. He set up his own clinic only four years after graduating as a naturopathic doctor. 

Dr Callas has been prescribing Low Dose Naltrexone (LDN) for over four years and has seen great results, especially in his cancer patients ranging between 50-70 years old. Overall, he has seen many of his patients live much longer than what they were originally predicted. Not only that, their quality of life has also improved.

Likewise, in many of his autoimmune patients he has seen great recoveries with the help of LDN. Dr Callas is a vehement supporter of the use of LDN in treating cancer and autoimmune patients.

This is a summary of Dr Patrick Callas’ interview. Please listen to the rest of Dr Callas’ story by clicking on the video above.

 

Dr Pat Crowley, LDN Radio Show 18 Dec 2016 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr Pat Crowley shares his Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood.

Dr Pat Crowley is a retired GP from Kilkenny in Ireland, and he's been prescribing Low Dose Naltrexone (LDN) since 2004. He graduated from a university college in Dublin in 1968 and went on to have an extensive 40-year career in the pharmaceutical industry.

Throughout his career he has noticed the incredible benefits LDN has had to offer for not only his autoimmune patients, but also many cancer patients. Additionally, there has been instances which Dr Crowley has noticed where LDN has been effective in treating addictions such as Alcoholism.

This is a summary of Dr Pat Crowley’s interview. Please listen to the rest of Dr Crowley’s story by clicking on the video.

Dr Mark Shukhman, LDN Radio Show 2017 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr Mark Shukhman shares his Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood.

Psychiatrist Dr Mark Shukhman practices in the suburbs of Chicago. Belmont Pharmacy is a nationally respected compounding pharmacy which compounds Low Dose Naltrexone (LDN) and bioidentical hormones, as well as a number of custom amino acids and mineral blends. They're based in Colorado and ship nationwide. Their goal is better patient outcomes through quality compounding, combining effective communication between practitioner, pharmacist, and patient.

In this interview, Dr Shukman focuses upon the psychological impact of autoimmune diseases and how LDN can help patients to recover from difficult experiences as well as boosting their immune systems.

This is a summary of Dr Mark Shukhman’s interview. Please listen to the rest of Dr Shukhman’s story by clicking on the video above.

Dr Kathleen MacIsaac, LDN Radio Show 2016 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr. Kathleen MacIsaac is from Florida in the United States. She first heard about LDN around 2006 while researching a different topic. It made sense biochemically, so she started using LDN in her patients, to treat fibromyalgia, chronic pain, migraine, and insomnia. She noted great response in reduction in pain and increased quality of sleep in fibromyalgia patients. More recently she is using LDN for Hashimoto’s thyroiditis; and chronic neurologic disorders including MS (multiple sclerosis), ALS (amyotrophic lateral sclerosis), and PLS (progressive lateral sclerosis). While the neurologic issues haven’t had complete resolution, the patients’ quality of life has improved, and there has been improvement in coordination, articulation, and swallowing. She has a pediatric patient on LDN for autism.

Less than 10 of her patients stopped using LDN, because they didn't notice any improvement or because they did not like a side effect, such as vivid dreams, or nausea, or some GI side effect. Those patients tended to start with milder conditions, thus less motivation to work through the side effects than ones with more debilitating conditions. There is a gap of time it takes to adapt. Most recently Dr. MacIsaac will start very low and progress upwards in dose slowly. Rather than a common titration like LDN 1.5 mg, then 3.0 mg, then 4.5 mg, she has the compounding pharmacy prepare a suspension so patients can titrate up by 0.5 mg over a longer period of time. Some patients remain on very low doses of less than a milligram, and she found it interesting that that small amount is adequate.

Linda Elsegood commented on various approaches she is aware of to lower the dropout rate for LDN, such as starting very low doses, taking LDN in the morning if there are sleep issues, and sublingual drops that are absorbed and bypass the stomach for patients with GI problems.

Dr. MacIsaac has 3 recent patients using daytime dosing of LDN for smoking and alcohol dependency issues, and it’s as if LDN doctors the brain to have less craving for nicotine or alcohol. It’s a new method of treatment for Dr. MacIsaac, and she is pursuing it further.

Linda Elsegood added that LDN is being used to treat OCD, and PMS; and Dr. Phil Boyle uses LDN in treating infertility and other gynecologic issues. Linda is aware of at least one woman whose PCOS (polycystic ovary syndrome) was improved on LDN. Linda relates that she herself had many issues with endometriosis from age 11, and a surprise added benefit when she began LDN for her MS, was her endometriosis issues cleared up. Dr. MacIsaac has found the LDN Research Trust website to be a good resource, and is learning a lot more about LDN.

Dr. MacIsaac’s practice is Healing Alternatives in Orlando Florida, and the website is http://www.healingalternativesinc.com/. The office phone is 407-682-711.

Summary from Dr. Kathleen MacIsaac, listen to the video for the show.

Keywords: LDN, low dose naltrexone, fibromyalgia, chronic pain, migraine, insomnia, Hashimoto’s, multiple sclerosis, MS, ALS, amyotrophic lateral sclerosis, PLS, progressive lateral sclerosis, autism, compounding pharmacy, alcohol, smoking, nicotine, infertility, endometriosis, OCD, PMS,  PCOS, polycystic ovary syndrome

Dr Jill Cottel, LDN Radio Show 26 July 2018 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

The number of patients with autoimmune disease Dr. Cottel is seeing has increased, particularly thanks to her presence on the LDN Research Trust website. She also is treating more patients with alcohol use disorder (AUD) with LDN than before, with very good results.

Q: In a patient with a pain disorder, on 4.5mg LDN without good result, should he increase his dose?

A: Essentially, if you’re not getting relief on lower doses, it may work increasing the dose, but it is not well studied. Linda commented on reaching opiate blockade and the need to reduce the dose.

Q: Address where a patient with Sjogren’s has GI side effects from LDN even at ultra-low doses.

A: Have compounding pharmacy prepare LDN in water at 1mg/ml and start at a very low dose eg 0.1mg and increase by 0.1mg as tolerated, slowly. Take at bedtime. Linda commented that sublingual drops work very well also to avoid GI absorption.

Q: In a patient with MS on LDN 3.0mg developed double vision, is higher dose LDN advised? What about Vitamin K2 for MS, will it re-wrap the nerves? Can Mediterranean diet decrease inflammation?

A: Always have double vision checked to be sure of cause. If from MS, increasing LDN to 4.5mg may help. As for Vitamin K2, some studies suggest K2 may inhibit inflammation of anti-microglial cells, and perhaps the body could heal itself. Yes, that diet decreases inflammation; diet is very important in treating autoimmune disease.

Q: Patient with Hashimoto’s starting LDN, what side effects should be looked for.

A: Typically, LDN is well tolerated. Perhaps headaches or vivid dreams early on, and patients with GI problems may have diarrhea.

Q: Can LDN help fibromyalgia and cancer prevention?

A: Yes for fibromyalgia, but not everyone goes into full remission. Probably yes for cancer prevention; there are animal studies to support that, as well as that LDN is used in treatment of cancer.

Q: Patient on prednisolone for polymyalgia and can’t get off steroids. Will LDN help?

A: Yes, recommend adding LDN then tapering steroids. There are complications from chronic steroid use.

Q: Can LDN and thyroid medications be taken at the same time?

A: Thyroid medications are to be taken alone, at least 1 hour from other medications.

Q: Is LDN for real?

A: Yes! There are lots of sources for information from prescribers, patients, and through small studies.

Q: Use LDN in post-polio syndrome?

A: In her one patient with post-polio syndrome, LDN has helped with the pain, but in post-polio syndrome there are many sources for pain, and as LDN is so well tolerated, she recommends its use.

Q: How do you know LDN is working (patient with Hashimoto’s)? Can gluten ever be re-introduced?

A: Clinical response is the indicator of success in Hashimoto’s. Dr. Tom O’Bryan has a series on this. Once you have antibodies to gluten, they will increase when exposed to gluten, and can interfere with how LDN works.

< Note: the LDN App was retired >

Q: Will LDN help with pernicious anemia and rheumatoid arthritis (RA) and how do I get it?

A: Get information from the LDN Research Trust website to take to your doctor. LDN is an immune modulator and calms RA. Pernicious anemia is an autoimmune disorder, traditionally treated with B12 injections so use of LDN and pernicious anemia would be interesting to study.

Q: Can you take LDN and Chantix, a medication used for smoking cessation? Are there studies on LDN and vitiligo?

A: LDN may help with smoking cessation and Chantix. Linda has heard of patient using LDN for vitiligo with great success.

Q: Can going on/off LDN be a problem?

A: For those on LDN for a long time, it’s not likely to cause a problem, but you may notice a return of symptoms.

Q: In Type I diabetes and alopecia universalis

A: Dr. Cottel has seen few cases but has not seen great success with LDN. Linda noted she has spoken with patients who had great success with LDN for alopecia; but LDN is not a miracle drug nor does it work in all people.

Q: Is it ok to take LDN for fibromyalgia with thyroid medication?

A: They can be taken together, but be sure to take them at least an hour apart.

Q: Hashimoto’s and Sjogren’s who is pregnant. Is LDN safe during pregnancy?

A: Dr. Phil Boyle covered this at the last conference: no problems taking LDN during pregnancy

Q: Can LDN be used in Crohn’s disease the same way as the immunosuppressants used?

A: LDN is effective in some patients with Crohn’s disease and might allow tapering off other immunosuppressants.

Q: Can LDN be used in patients with glioblastoma?

A: Many prescribers use LDN in treating cancer as part of a complete treatment program.

Q: If LDN helps with pain in a neuropathic pain condition, does it mean the condition is autoimmune?

A: No. You can get pain relief from the endorphin effect of LDN.

This is a summary. Please listen to the full interview.

Dr Greg Carder, LDN Radio Show 28 June 2017 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr Greg Carder shares his Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood.

Dr Greg Carder operates an integrative clinic that specializes in Physical Medicine and Rehabilitation. His group are fixated on Anti-aging and have many therapies that repair and improve our minds and bodies so that we can live better and longer lives. 

Low Dose Naltrexone (LDN) is one of their many tools and 50% of their patients are prescribed this effective drug. Dr Carder is visionary and ahead of the average doctor in his approach to health.

This interview is full of humour while Dr Carder explains why LDN is such a successful drug.

This is a summary of Dr Greg Carder’s interview. Please listen to the rest of Dr Carder’s interview by clicking on the video above.